Worth reading
65In focus
Scored from 4 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
1823
million yen (decrease in operating profit)Wording
Conditional
How definitive the wording is.Results for this period
Full year1 April 2025 to 31 March 2026ConsolidatedJapanese GAAPNet Sales96,300¥ millionYear on year +0.8%Progress 96.3%
Operating profit6,900¥ millionYear on year -20.9%Progress 97.2%
Ordinary income7,704¥ millionYear on year -18.2%Progress 101.4%
Net income attributable to owners of the parent7,035¥ millionYear on year -25.1%Progress 93.8%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥238.19
Operating Margin7.2%
Financial position at period-end
Total assets116,387¥ million
of which net assets 83,379 ¥ millionEquity ratio 71.6%vs. prior year-end +1.5pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+5,963
Investment+1,747
Financials-8,040
Net change-330
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥19,131 million
Segment revenueDomestic Food Business ¥66,360 million (YoY +2.4%), Domestic Chemical Products and Other Businesses ¥8,686 million (YoY +9.1%), Overseas Business ¥22,893 million (YoY -5.4%)
Segment profitDomestic Food Business ¥6,417 million, Domestic Chemical Products and Other Businesses ¥857 million, Overseas Business ¥-436 million
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥100,000 million (YoY +3.8%)
Operating profit¥7,100 million (YoY +2.9%)
Ordinary income¥7,600 million (YoY -1.4%)
Net income¥7,500 million (YoY +6.6%)
Annual Dividend Forecast¥110 → ¥110（0.0%）
Payout ratio46.2% (42.8% forecast for the fiscal year ending March 2027)
Factors Behind Changes in Business Performance
Net sales from the Overseas Business were below the previous fiscal year, while sales from the Domestic Food Business and Domestic Chemicals and Other Business exceeded the previous fiscal year. On the profit front, results were affected by higher labor costs, depreciation, personnel expenses and fees, insufficient benefits from price revisions, lower revenue from the Overseas Business, and a change in the estimate for asset retirement obligations related to asbestos removal costs.
Disclosure regarding the going concern assumption
Not applicable.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 Yes修正再表示 No
Changes in the scope of consolidationNew 2 companies / Name of newly added company RIKEVITA VIET NAM CO., LTD., RIKEVITA(THAILAND)CO., LTD. / Excluded 0 companies
Material subsequent eventsAt a meeting of the Board of Directors held on 13 May 2026, the company resolved to repurchase its own shares to enhance shareholder returns and improve capital efficiency. The number of shares to be acquired is up to 900,000, the acquisition cost is up to ¥2,000,000,000, and the acquisition period is from 1 June to 30 September 2026.
Breakdown of extraordinary income (loss)Extraordinary income Item Gain on sale of non-current assets / Amount ¥11 million, Item Gain on sale of investment securities / Amount ¥2,584 million, Item Subsidy Income / Amount ¥238 million, Item Insurance proceeds received / Amount Not disclosed / Extraordinary loss Item Loss on sale of fixed assets / Amount ¥99 million, Item Losses from natural disasters / Amount Not disclosed, Item Loss on Disposal of Fixed Assets / Amount ¥87 million, Item Loss on reduction of fixed assets / Amount ¥87 million, Item Loss on sale of investment securities / Amount ¥2 million, Item Impairment loss on investment securities / Amount Not disclosed, Item Valuation loss on investments in affiliates / Amount ¥19 million, Item Losses related to business reorganization / Amount Not disclosed, Item Loss on revision of retirement benefit plans / Amount Not disclosed
Depreciation and amortization¥4,677 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingYes (for securities analysts and institutional investors)
Issued Shares at Period-End30,705,100 shares
Treasury Shares at Period-End1,517,289 shares
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025 to 31 March 2026 |
| Net Sales | ¥96,300 million (YoY +0.8%) |
| Operating profit | ¥6,900 million (YoY -20.9%) |
| Ordinary income | ¥7,704 million (YoY -18.2%) |
| Profit attributable to owners of the parent | ¥7,035 million (YoY -25.1%) |
| Net income per share | ¥238.19 |
| Operating Margin | 7.2% |
| Equity ratio | End of the current fiscal period 71.6 / End of previous period 70.1 |
| Total assets | ¥116,387 million |
| Net assets | ¥83,379 million |
| Cash flows from operating activities | ¥5,963 million |
| Cash flows from investing activities | ¥1,747 million |
| Cash flows from financing activities | ¥-8,040 million |
| Cash and cash equivalents at end of period | ¥19,131 million |
| Full-year earnings forecast | Net Sales ¥100,000 million (YoY +3.8%) / Operating profit ¥7,100 million (YoY +2.9%) / Ordinary income ¥7,600 million (YoY -1.4%) / Net income ¥7,500 million (YoY +6.6%) |
| Annual Dividend Forecast | ¥110 → ¥110（0.0%） |
| Payout ratio | 46.2% (42.8% forecast for the fiscal year ending March 2027) |
| Segment revenue | Domestic Food Business ¥66,360 million (YoY +2.4%), Domestic Chemical Products and Other Businesses ¥8,686 million (YoY +9.1%), Overseas Business ¥22,893 million (YoY -5.4%) |
| Segment profit | Domestic Food Business ¥6,417 million, Domestic Chemical Products and Other Businesses ¥857 million, Overseas Business ¥-436 million |
| Depreciation and amortization | ¥4,677 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Item Gain on sale of non-current assets / Amount ¥11 million, Item Gain on sale of investment securities / Amount ¥2,584 million, Item Subsidy Income / Amount ¥238 million, Item Insurance proceeds received / Amount Not disclosed / Extraordinary loss Item Loss on sale of fixed assets / Amount ¥99 million, Item Losses from natural disasters / Amount Not disclosed, Item Loss on Disposal of Fixed Assets / Amount ¥87 million, Item Loss on reduction of fixed assets / Amount ¥87 million, Item Loss on sale of investment securities / Amount ¥2 million, Item Impairment loss on investment securities / Amount Not disclosed, Item Valuation loss on investments in affiliates / Amount ¥19 million, Item Losses related to business reorganization / Amount Not disclosed, Item Loss on revision of retirement benefit plans / Amount Not disclosed |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate Yes / Restatement No |
| Changes in the scope of consolidation | New 2 companies / Name of newly added company RIKEVITA VIET NAM CO., LTD., RIKEVITA(THAILAND)CO., LTD. / Excluded 0 companies |
| Material subsequent events | At a meeting of the Board of Directors held on 13 May 2026, the company resolved to repurchase its own shares to enhance shareholder returns and improve capital efficiency. The number of shares to be acquired is up to 900,000, the acquisition cost is up to ¥2,000,000,000, and the acquisition period is from 1 June to 30 September 2026. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for securities analysts and institutional investors) |
| Issued Shares at Period-End | 30,705,100 shares |
| Treasury Shares at Period-End | 1,517,289 shares |
| Factors Behind Changes in Business Performance | Net sales from the Overseas Business were below the previous fiscal year, while sales from the Domestic Food Business and Domestic Chemicals and Other Business exceeded the previous fiscal year. On the profit front, results were affected by higher labor costs, depreciation, personnel expenses and fees, insufficient benefits from price revisions, lower revenue from the Overseas Business, and a change in the estimate for asset retirement obligations related to asbestos removal costs. |
Items this document does not state (5)
Revision to Earnings ForecastShareholder Return PolicyRegional salesOrders received and order backlogImpairment loss
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company explained that higher costs, including labor costs, depreciation, personnel expenses and fees, insufficient benefits from price revisions, and lower revenue from overseas operations, together with a change in the estimate for asset retirement obligations related to asbestos removal costs, weighed on profit.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.